Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increasing age does not decrease risk of schizophrenia up to age 40.

Jari Haukka1, Jaana Suvisaari, Jouko Lönnqvist

  • 1Department of Mental Health and Alcohol Research, KTL, National Public Health Institute, Mannerheimintie 160, FIN-00300 Helsinki, Finland. jari.haukka@ktl.fi

Schizophrenia Research
|March 22, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of symptoms and illness insight on treatment adherence in first-episode psychosis: a one-year follow-up study using therapeutic drug monitoring.

BMC psychiatry·2026
Same author

Achieving equity requires investment in vulnerable populations.

The Lancet. Public health·2026
Same author

Health care personnel under the pressure of COVID-19 - a prospective 2-year cohort study.

Nordic journal of psychiatry·2025
Same author

Alcohol use, daily smoking, clozapine use and psychiatric symptom profile in persons with schizophrenia spectrum disorder.

Nordic journal of psychiatry·2025
Same author

Treatment adherence in first-episode psychosis: A one-year follow-up study comparing self-reported adherence, pharmacy refill data, and therapeutic drug monitoring.

Psychiatry research·2025
Same author

Complement C4 gene copy numbers modulate serum immune protein profiles in patients with first-episode psychosis and healthy controls in a sex-specific manner.

Schizophrenia research·2025
Same journal

Weight loss and gut microbial changes associated with semaglutide among people living with schizophrenia receiving clozapine or olanzapine: An open-label 24-week semaglutide intervention and 76-week trial.

Schizophrenia research·2026
Same journal

Converting negative symptom dimension scores across SANS and PANSS.

Schizophrenia research·2026
Same journal

Inflammation-associated alterations in mGluR transcript expression in the human nucleus accumbens independent of schizophrenia diagnosis.

Schizophrenia research·2026
Same journal

One social interaction after another: Dynamic modeling of social experience in schizophrenia.

Schizophrenia research·2026
Same journal

Reduced synaptic plasticity and E/I imbalance drive peripersonal space boundaries expansion in schizophrenia.

Schizophrenia research·2026
Same journal

Complete blood count-derived inflammatory markers and symptom phenotypes in schizophrenia spectrum disorders: A hierarchical clustering analysis.

Schizophrenia research·2026
See all related articles

Schizophrenia risk increases with age for susceptible individuals, particularly males. The proportion of susceptible individuals appears lower in younger birth cohorts, suggesting evolving risk factors for schizophrenia.

Area of Science:

  • Psychiatry and Epidemiology
  • Statistical Modeling in Public Health

Background:

  • Population-level schizophrenia incidence peaks in early adulthood.
  • Traditional models do not account for population susceptibility variations.

Purpose of the Study:

  • To investigate schizophrenia incidence assuming partial population susceptibility.
  • To analyze age-specific risk within a susceptible sub-population.

Main Methods:

  • Analysis of Finnish birth cohorts (1950-1968) followed until age 40.
  • Application of a compound Poisson statistical model to estimate susceptibility proportion.
  • Examination of hazard distribution and sex-specific risk patterns.

Main Results:

  • Individual risk of schizophrenia increases with age up to 40 within the susceptible group.

Related Experiment Videos

  • Risk increase is more pronounced in males.
  • The proportion of susceptible individuals was similar across sexes but lower in younger cohorts.

    • Conclusions:

    • Schizophrenia risk escalates with age for susceptible individuals, with a faster rate in males.
    • The declining proportion of susceptibles in younger cohorts warrants further investigation.
    • Underlying reasons for sex differences and cohort effects remain unclear.